Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.
Blanco E. et al, (2025), The Journal of experimental medicine, 222
The impact of inversions across 33,924 families with rare disease from a national genome sequencing project
Pagnamenta AT. et al, (2024), The American Journal of Human Genetics, 111, 1140 - 1164
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
Pagnamenta AT. et al, (2023), Genome Medicine, 15
Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.
Shoemark A. et al, (2022), The European respiratory journal, 60
Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis
Shoemark A. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60
The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).
Seligmann JF. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency
Rota IA. et al, (2021), Science Advances, 7
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report
(2021), New England Journal of Medicine, 385, 1868 - 1880
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications.
Camps C. et al, (2021), JCO oncology practice, 17, e1162 - e1169
dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A. et al, (2021), Expert review of molecular diagnostics, 21, 3 - 15
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer.
Torres S. et al, (2020), Expert review of molecular diagnostics, 20, 575 - 582
Strategies for increasing diagnostic rate in patients with primary immunological disorders within the Genomics England 100,000 Genomes Project
Camps C. et al, (2020), EUROPEAN JOURNAL OF HUMAN GENETICS, 28, 106 - 106
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Schwarze K. et al, (2020), Genetics in Medicine, 22, 85 - 94
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Domingo E. et al, (2018), The Lancet Gastroenterology & Hepatology, 3, 635 - 643
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease
Lenglet M. et al, (2018), Blood, 132, 469 - 483
Isolated erythrocytosis as the first symptom of congenital hypermanganesemia due to homozygous mutation in the SLC30A10 gene
Cario H. et al, (2018), ONCOLOGY RESEARCH AND TREATMENT, 41, 194 - 194
Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
Camps C. et al, (2018), EUROPEAN JOURNAL OF HUMAN GENETICS, 26, 675 - 676
Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A. et al, (2017), Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 19, 651 - 657
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.
Rosell R. et al, (2017), The Lancet. Respiratory medicine, 5, 435 - 444
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M. et al, (2017), Clinical lung cancer, 18, 178 - 188.e4